Andrew Chandler

Andrew Chandler

Auto-generated profile, based on publicly available information

Andrew Chandler

University of Chichester

Research Focus & Metrics

Academic Career Length

33Years (1994-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2021 in Molecular Cancer Therapeutics
Verified
Journal Article
Open access
PDF file
TFTomohiro Fujiwara
Tomohiro Fujiwara
MYMohamed A. Yakoub
Mohamed A. Yakoub
ACAndrew Chandler
Andrew Chandler
ACAlexander Bryant Christ
Alexander Bryant Christ
GYGuangli Yang
Guangli Yang
JHJohn Healey
John Healey
Colony-stimulating factor 1 (CSF1) is a primary regulator of the survival, proliferation, and differentiation of monocyte/macrophage that sustains the protumorigenic functions of tumor-associated macrophages (TAMs). Considering current advances in understanding the role of the inflammatory tumor microenvironment, targeting the components of the sarcoma microenvironment, such as TAMs, is a viable strategy. Here, we investigated the effect of PLX3397 (pexidartinib) as a potent inhibitor of the CSF1 receptor (CSF1R). PLX3397 was recently approved by the Food and Drug Administration (FDA) to treat tenosynovial giant cell tumor and reprogram TAMs whose infiltration correlates with unfavorable prognosis of sarcomas. First, we confirmed by cytokine arrays of tumor-conditioned media (TCM) that cytokines including CSF1 are secreted from LM8 osteosarcoma cells and NFSa fibrosarcoma cells. The TCM, like CSF1, stimulated ERK1/2 phosphorylation in bone marrow–derived macrophages (BMDMs), polarized BMDMs toward an M2 (TAM-like) phenotype, and strikingly promoted BMDM chemotaxis. In vitro administration of PLX3397 suppressed pERK1/2 stimulation by CSF1 or TCM, and reduced M2 polarization, survival, and chemotaxis in BMDMs. Systemic administration of PLX3397 to the osteosarcoma orthotopic xenograft model significantly suppressed the primary tumor growth and lung metastasis, and thus improved metastasis-free survival. PLX3397 treatment concurrently depleted TAMs and FOXP3+ regulatory T cells and, surprisingly, enhanced infiltration of CD8+ T cells into the microenvironments of both primary and metastatic osteosarcoma sites. Our preclinical results show that PLX3397 has strong macrophage- and T-cell–modulating effects that may translate into cancer immunotherapy for bone and soft-tissue sarcomas.

20 October 2021 in Journal of Osteopathic Medicine
Verified
Journal Article
Open access
PDF file
AAAbraham Abdulrazzak
Abraham Abdulrazzak
ACAndrew Chandler
Andrew Chandler
RLRosemary Lu
Rosemary Lu
OMOlivia Mobarakai
Olivia Mobarakai
BLBryan Lebron
Bryan Lebron
SFStacey L. Fanning
Stacey L. Fanning
Context: The percent of underrepresented minority (URM) students who apply to medical school has changed minimally in the past 40 years. Due to the lack of URM applicants, the consequent matriculation of URMs is grossly disproportionate from their percent representation of the US population. Increasing diversity among medical students and physicians has previously been identified as essential to decreasing healthcare disparities among US minorities. Objectives: The objective of our study was to recognize the barriers of applying to medical school among URMs in high school. Methods: To identify and assess the prevalence of barriers, surveys were distributed to participants of Med-Achieve, a mini-medical school program of diverse high school students in New York City during the 2019–2020 academic year. Results: Among students who will be first in their immediate family to attend college, 80.0% perceived a barrier to pursuing medical school. Specified barriers indicated include the cost of medical school (77%), a lack of guidance/role models (53.9%), and the predicted inability to do well in medical school classes (53.9%). At the end of the program, a statistically significant reduction in the barrier of lack of guidance/role models was seen. Conclusions: This study highlights the benefit of mini-medical school programs, especially programs with a mentoring component, to decrease the perceived barriers of applying to medical school among URMs. It also suggests the potential role of similar programs to increase diversity in medicine and to decrease healthcare disparities among minorities in the United States.

25 November 2020 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
SAShane D. Anderson
Shane D. Anderson
ATAsna Tabassum
Asna Tabassum
JYJae Kyung Yeon
Jae Kyung Yeon
GSGarima Sharma
Garima Sharma
PSPriscilla Santos
Priscilla Santos
BABradley T. Andresen
Bradley T. Andresen
Angiotensin II type 1 receptor (AT1R) blockers (ARBs) are among the most prescribed drugs. However, ARB effectiveness varies widely, which may be due to non-synonymous single nucleotide polymorphisms (nsSNPs) within the AT1R gene. The AT1R coding sequence contains over 100 nsSNPs; therefore, this study embarked on determining which nsSNPs may abrogate the binding of selective ARBs. The crystal structure of olmesartan-bound human AT1R (PDB:4ZUD) served as a template to create an inactive apo-AT1R via molecular dynamics simulation (n = 3). All simulations resulted in a water accessible ligand-binding pocket that lacked sodium ions. The model remained inactive displaying little movement in the receptor core; however, helix 8 showed considerable flexibility. A single frame representing the average stable AT1R was used as a template to dock Olmesartan via AutoDock 4.2, MOE, and AutoDock Vina to obtain predicted binding poses and mean Boltzmann weighted average affinity. The docking results did not match the known pose and affinity of Olmesartan. Thus, an optimization protocol was initiated using AutoDock 4.2 that provided more accurate poses and affinity for Olmesartan (n = 6). Atomic models of 103 of the known human AT1R polymorphisms were constructed using the molecular dynamics equilibrated apo-AT1R. Each of the eight ARBs was then docked, using ARB-optimized parameters, to each polymorphic AT1R (n = 6). Although each nsSNP has a negligible effect on the global AT1R structure, most nsSNPs drastically alter a sub-set of ARBs affinity to the AT1R. Alterations within N298 –L314 strongly effected predicted ARB affinity, which aligns with early mutagenesis studies. The current study demonstrates the potential of utilizing in silico approaches towards personalized ARB therapy. The results presented here will guide further biochemical studies and refinement of the model to increase the accuracy of the prediction of ARB resistance in order to increase overall ARB effectiveness.

2 December 2021 in Journal of Orthopaedic Research
Verified
Journal Article
Closed access
PDF file
ACAndrew C. Chandler
Andrew C. Chandler
MYMohamed Yakoub
Mohamed Yakoub
TFTomohiro Fujiwara
Tomohiro Fujiwara
LDLaura T. Donlin
Laura T. Donlin
PPPaul Edward Purdue
Paul Edward Purdue
JHJohn Healey
John Healey

1 November 1994 in Twentieth Century British History
Verified
Journal Article
Closed access
PDF file
ACAndrew Chandler
Andrew Chandler
ANDREW CHANDLER; Munich and Morality: The Bishops of the Church of England and Appeasement, Twentieth Century British History, Volume 5, Issue 1, 1 November 19